Injections can reduce skin rashes and itches from severe eczema in children under 5, study finds

Scientists at Northwestern University in Illinois , found the monoclonal antibody Dupilumab – sold under the brand name Dupixent – cut eczema symptoms by at least 75 percent in half of children.Scientists at Northwestern University in Illinois , found the monoclonal antibody Dupilumab – sold under the brand name Dupixent – cut eczema symptoms by at least 75 percent in half of children.Read MoreHealth News | Mail Online